These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Variation of serum free amino acids in fulminant hepatitis treated with hepatic assists (author's transl)]. Tsuji Y; Kondo M; Matsushita M; Koshino I; Kon T; Sawada Y; Kasai Y Hokkaido Igaku Zasshi; 1980 Jan; 55(1):59-65. PubMed ID: 7409729 [TBL] [Abstract][Full Text] [Related]
3. [Progress in artificial liver for blood purification]. Kodama M; Oka T; Tani T; Hanazawa K Nihon Rinsho; 1985 Dec; 43(12):2605-10. PubMed ID: 3915024 [No Abstract] [Full Text] [Related]
4. A fulminant hepatitis associated with acute renal failure: an indication for hemodialysis and hemoperfusion. Shinoda T; Hayashi H; Kakumu S; Rhyuge J; Kawahara H; Ohokura T; Sakamoto N Gastroenterol Jpn; 1979; 14(3):211-5. PubMed ID: 447000 [No Abstract] [Full Text] [Related]
7. [Treatment and nursing of a patient with fulminant hepatitis saved by hemoperfusion]. Sakuma A; Miyazaki N; Masumori S; Shiba A; Adachi H Kango Gijutsu; 1981 Jan; 27(1):57-65. PubMed ID: 6907419 [No Abstract] [Full Text] [Related]
8. [The effect of hemoperfusion through activated charcoal on middle molecular substances in the plasma during a long-term dialysis program]. Mydlík M; Dzúrik R; Derzsiová K; Spustová V Cas Lek Cesk; 1983 Dec; 122(51):1573-6. PubMed ID: 6652672 [No Abstract] [Full Text] [Related]
9. [The significance of blood coagulation test in fulminant hepatic failure]. Kawamura A; Meguro J; Kukita K; Yonekawa M; Imai K; Kobayashi N; Kawamura K; Kasai M Hokkaido Igaku Zasshi; 1988 Sep; 63(5):805-10. PubMed ID: 3240924 [TBL] [Abstract][Full Text] [Related]
10. Assessments of clinical trials of charcoal hemoperfusion in uremic patients. Chang TM Clin Nephrol; 1979 Feb; 11(2):111-9. PubMed ID: 378489 [No Abstract] [Full Text] [Related]
11. [Use of enterodesis in the complex treatment of patients with pronounced chronic renal failure]. Del'machinskiĭ BV; Ermolenko VM; Lifshits NL; Suzdaleva VV; Makarova NL Ter Arkh; 1988; 60(8):89-91. PubMed ID: 3227485 [No Abstract] [Full Text] [Related]
12. First experience with clinical use of an original hemoperfusion system. Horký J; Horák J; Tlustáková M; Kálal J Czech Med; 1981; 4(1-2):67-80. PubMed ID: 7261808 [TBL] [Abstract][Full Text] [Related]
14. Clinical experience with prolonged combined hemoperfusion-hemodialysis treatment of severe poisoning. De Broe ME; Verpooten GA; Christiaens MA; Rutsaert RJ; Holvoet J; Nagler J; Heyndrickx A Artif Organs; 1981 Feb; 5(1):59-66. PubMed ID: 7247757 [TBL] [Abstract][Full Text] [Related]
15. Assessment of bilirubin clearance capacity of a newly developed ion-exchange adsorption column and its possible use as a supportive therapy in hepatorenal syndrome. Sone J; Saibara T; Himeno H; Yamasaki K; Miyamoto K; Maeda T; Onishi S; Yamamoto Y; Park K; Okumiya T J Clin Apher; 1990; 5(3):123-7. PubMed ID: 2345158 [TBL] [Abstract][Full Text] [Related]
16. [Hemoperfusion and plasma exchange therapy in patients with paraquat poisoning]. Kuwahara M; Takagi N; Nishitani M; Matsushita K; Nakamura K; Fujisaki N Hinyokika Kiyo; 1994 May; 40(5):439-42. PubMed ID: 8023769 [TBL] [Abstract][Full Text] [Related]
17. [The use of an ozonized sorbent in treating patients with progressive pulmonary tuberculosis combined with hepatitis]. Belianin II; Shmelev EI Ter Arkh; 1994; 66(2):29-32. PubMed ID: 8160139 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of acute drug poisoning with hemoperfusion through active coal and dialysis]. García Pérez JJ; Méndez Pérez ML; Redondo Rodríguez M; Hernández Calzadilla C; García Pérez F; Maceira Cruz B; Hernández Nieto L Rev Clin Esp; 1980 Mar; 156(6):413-8. PubMed ID: 7394220 [No Abstract] [Full Text] [Related]